Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › Ravenna › NPI 1043641897
Hospital

Robinson Health System, INC.

Robinson Health System, INC. was paid $26.26M by Medicaid between Jan 2018 and Dec 2024, across 356 billing codes. Its largest line is 99283, emergency room visit (moderate) — 17% of everything it billed.

33Billing provider infoROBINSON HEALTH SYSTEM, INC.
RAVENNA, OH 44266
33aNPI1043641897assigned 12/04/2013
28Total paid$26.26M
24GClaims667,857
24DCodes billed356
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Ohio

Rank by total paid#45 of 101
Median peer was paid$22.32M
This provider vs. median1.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official SCHILLERO, ANTHONY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$500K$1.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201868,929$2.39M
201957,892$2.15M
202047,612$2.36M
202166,166$2.93M
202263,759$2.83M
2023209,813$8.20M
2024incomplete153,686$5.42M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 17% 37,859 34,946 $4.53M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 12% 23,301 20,610 $3.07M
96361 Intravenous infusion, hydration; each additional hour 8.0% 7,790 6,302 $2.09M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 7.0% 15,750 13,605 $1.83M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 6.4% 13,318 12,437 $1.67M
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 6.2% 13,858 13,118 $1.62M
70450 Computed tomography, head or brain; without contrast material 3.2% 3,585 2,914 $849K
74177 Computed tomography, abdomen and pelvis; with contrast material 2.9% 3,430 2,729 $764K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.9% 10,990 3,462 $759K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 1.5% 3,972 1,931 $402K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.5% 2,737 1,840 $389K
80053 Comprehensive metabolic panel 1.3% 31,949 27,063 $354K
344 more codes
74176 Computed tomography, abdomen and pelvis; without contrast material 1.1% 1,102 $297K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.1% 1,139 $289K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 1.0% 1,516 $273K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.0% 10,195 $268K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.0% 1,299 $267K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 1.0% 718 $264K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 1,217 $260K
71275 Computed tomographic angiography, chest, with contrast material <1% 925 $236K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 3,048 $226K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 2,012 $218K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,270 $216K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 433 $189K
99215 Doctor's office visit, returning patient (complex) <1% 1,967 $177K
86481 <1% 2,607 $170K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 5,254 $159K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 4,256 $137K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 4,220 $114K
86780 <1% 2,939 $113K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 822 $109K
80048 Basic metabolic panel (calcium, ionized) <1% 12,796 $102K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 792 $99K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 903 $98K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 42,812 $92K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 2,096 $91K
80355 <1% 4,869 $86K
71046 Radiologic examination, chest; 2 views <1% 9,126 $85K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 967 $84K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 2,901 $82K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 237 $77K
G0378 Hospital observation service, per hour <1% 1,597 $76K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 104 $74K
36415 Collection of venous blood by venipuncture <1% 31,779 $74K
82077 <1% 4,333 $70K
77063 Screening digital breast tomosynthesis, bilateral <1% 1,539 $69K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 241 $63K
84443 Thyroid stimulating hormone (TSH) <1% 4,076 $61K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 2,154 $58K
97161 <1% 1,259 $51K
76830 Ultrasound, transvaginal <1% 1,225 $51K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 88 $50K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,858 $47K
80074 <1% 2,706 $47K
76642 <1% 544 $47K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 3,766 $46K
85027 <1% 6,694 $46K
93017 <1% 607 $45K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 6,158 $45K
80061 Lipid panel <1% 3,493 $44K
93971 <1% 616 $42K
71250 <1% 496 $42K
73630 <1% 1,355 $41K
82805 <1% 1,714 $41K
87522 Neg quan hep c or qual rna <1% 674 $40K
97113 <1% 692 $40K
73030 <1% 1,125 $39K
76770 <1% 256 $38K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 86 $38K
71271 <1% 265 $37K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 381 $37K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 19,574 $37K
76536 <1% 340 $36K
88142 <1% 1,937 $36K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 283 $33K
11045 <1% 73 $33K
87205 <1% 2,023 $33K
83036 Hemoglobin; glycosylated (A1C) <1% 1,920 $30K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 914 $30K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 1,161 $30K
73562 <1% 614 $29K
12001 <1% 189 $28K
94060 <1% 261 $26K
87086 Culture, bacterial; quantitative colony count, urine <1% 3,721 $26K
73564 <1% 956 $25K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 16,431 $25K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 507 $24K
86140 <1% 1,339 $24K
80354 <1% 1,771 $24K
73130 <1% 991 $24K
73610 <1% 981 $22K
84484 <1% 10,197 $22K
93458 <1% 20 $22K
82607 <1% 776 $22K
97162 <1% 488 $22K
97535 Self-care/home management training, each 15 minutes <1% 725 $20K
73110 <1% 761 $20K
84439 <1% 829 $20K
80349 <1% 806 $19K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,538 $19K
78815 Positron emission tomography (PET) for limited area imaging <1% 29 $19K
97165 <1% 388 $18K
70491 <1% 71 $18K
73502 <1% 598 $18K
86850 <1% 1,040 $17K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 999 $17K
72125 Computed tomography, cervical spine; without contrast material <1% 1,419 $16K
72100 <1% 419 $15K
80353 <1% 1,001 $15K
70486 <1% 391 $15K
93975 <1% 95 $15K
72114 <1% 216 $14K
94726 <1% 273 $14K
70551 Magnetic resonance imaging, brain; without contrast material <1% 113 $14K
74018 <1% 430 $14K
71045 Radiologic examination, chest; single view <1% 3,718 $13K
80361 <1% 1,083 $13K
J1726 Injection, hydroxyprogesterone caproate, (makena), 10 mg <1% 1,431 $13K
80346 <1% 959 $12K
74183 <1% 49 $12K
96367 <1% 300 $12K
80320 <1% 838 $12K
73560 <1% 319 $12K
83605 <1% 7,201 $12K
82728 <1% 539 $11K
93296 <1% 676 $11K
94729 <1% 246 $11K
76982 <1% 237 $10K
72170 <1% 311 $9K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 1,549 $9K
86900 <1% 1,043 $9K
83735 <1% 4,856 $8K
80324 <1% 553 $8K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 3,809 $8K
96375 Therapeutic injection; each additional sequential IV push <1% 10,104 $8K
11043 <1% 55 $8K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 240 $7K
80348 <1% 1,183 $7K
90715 <1% 487 $7K
70496 <1% 19 $7K
80365 <1% 1,095 $7K
81001 <1% 14,342 $7K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 29 $7K
87634 <1% 353 $6K
93970 <1% 49 $6K
72131 <1% 128 $6K
96376 <1% 1,951 $6K
83540 <1% 531 $6K
82947 <1% 4,606 $6K
76801 <1% 52 $6K
77062 <1% 155 $5K
99152 <1% 424 $5K
82570 <1% 466 $5K
83992 <1% 256 $4K
72110 <1% 83 $4K
87070 <1% 561 $4K
87505 <1% 25 $4K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 28 $4K
85610 <1% 2,931 $4K
80358 <1% 671 $4K
76981 <1% 35 $4K
97116 <1% 321 $4K
80373 <1% 646 $4K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 16 $4K
73080 <1% 189 $4K
J3490 Unclassified drugs <1% 2,929 $3K
80368 <1% 632 $3K
73590 <1% 285 $3K
80372 <1% 609 $3K
80076 <1% 719 $3K
77065 Tomosynthesis, mammo <1% 158 $3K
81003 <1% 4,622 $3K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 79 $3K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 14 $3K
80331 <1% 256 $3K
80334 <1% 256 $3K
80337 <1% 256 $3K
80338 <1% 256 $3K
83880 <1% 1,888 $3K
80326 <1% 256 $3K
84702 <1% 1,355 $3K
80366 <1% 256 $3K
80344 <1% 256 $3K
80341 <1% 256 $3K
80370 <1% 256 $3K
80377 <1% 256 $3K
80367 <1% 256 $3K
80357 <1% 256 $3K
70498 <1% 37 $3K
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography <1% 14 $3K
12002 <1% 17 $3K
80360 <1% 256 $3K
80359 <1% 256 $3K
80364 <1% 256 $3K
80371 <1% 256 $3K
83690 <1% 4,842 $3K
81025 <1% 6,282 $3K
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg <1% 44 $2K
97035 <1% 26 $2K
93922 <1% 27 $2K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 511 $2K
80345 <1% 93 $2K
99201 <1% 47 $2K
82043 <1% 336 $2K
84100 <1% 794 $2K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 26 $2K
80069 <1% 204 $2K
87077 <1% 512 $2K
73140 <1% 99 $2K
72040 <1% 59 $2K
87186 <1% 875 $2K
80143 <1% 1,463 $2K
82248 <1% 695 $2K
86318 <1% 39 $1K
12011 <1% 15 $1K
86703 <1% 84 $1K
77080 <1% 24 $1K
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 475 $1K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 23 $1K
83550 <1% 115 $1K
72052 <1% 13 $1K
77066 Tomosynthesis, mammo <1% 187 $1K
J2270 Injection, morphine sulfate, up to 10 mg <1% 2,770 $1K
84466 <1% 106 $1K
86901 <1% 1,044 $1K
87800 <1% 223 $1K
71101 <1% 43 $1K
82330 <1% 1,290 $1K
00731 <1% 382 $1K
87040 <1% 1,420 $981.87
93246 <1% 14 $970.55
J1170 Injection, hydromorphone, up to 4 mg <1% 1,684 $961.61
72070 <1% 13 $883.74
J7030 Infusion, normal saline solution , 1000 cc <1% 10,212 $878.31
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 34 $870.13
73090 <1% 97 $854.56
82565 <1% 105 $842.04
80179 <1% 1,443 $826.46
J3535 Drug administered through a metered dose inhaler <1% 121 $811.84
87653 <1% 27 $752.34
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,930 $746.40
94618 <1% 15 $723.40
87210 <1% 291 $710.25
77061 <1% 12 $684.57
85018 <1% 1,340 $664.32
87075 <1% 1,127 $658.65
87799 <1% 22 $645.81
82550 <1% 512 $622.63
Q9957 Injection, perflutren lipid microspheres, per ml <1% 90 $621.61
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 71 $601.05
84132 <1% 1,328 $590.26
87493 <1% 23 $564.32
87340 <1% 47 $563.59
J7120 Ringers lactate infusion, up to 1000 cc <1% 3,019 $559.20
82435 <1% 1,219 $532.07
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 8,852 $516.66
85652 <1% 497 $511.95
87081 <1% 29 $456.22
85730 <1% 735 $419.36
82542 <1% 40 $411.67
85379 <1% 902 $404.92
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 13 $384.06
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 354 $379.62
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 666 $359.64
00812 <1% 48 $350.73
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 6,220 $321.89
J1644 Injection, heparin sodium, per 1000 units <1% 1,365 $319.33
84295 <1% 1,223 $316.70
99153 Mod sedat endo service >5yrs <1% 67 $298.47
80055 <1% 12 $268.81
J0500 Injection, dicyclomine hcl, up to 20 mg <1% 15 $257.97
87280 <1% 12 $248.16
00840 <1% 62 $244.60
94761 <1% 412 $226.46
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,394 $216.23
72128 <1% 30 $208.29
J3486 Injection, ziprasidone mesylate, 10 mg <1% 25 $199.50
J0689 Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg <1% 983 $198.79
J2704 Injection, propofol, 10 mg <1% 4,277 $186.49
C9113 Injection, pantoprazole sodium, per vial <1% 178 $184.46
80329 <1% 242 $181.62
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 8,388 $172.72
85007 <1% 34 $167.77
J8499 Prescription drug, oral, non chemotherapeutic, nos <1% 1,053 $167.13
J0780 Injection, prochlorperazine, up to 10 mg <1% 492 $149.17
82652 <1% 13 $148.60
94760 <1% 3,510 $137.86
J3370 Injection, vancomycin hcl, 500 mg <1% 431 $135.98
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 964 $129.69
J3010 Injection, fentanyl citrate, 0.1 mg <1% 3,920 $117.75
84481 <1% 12 $110.84
83721 <1% 12 $106.64
G0404 Electrocardiogram, routine ecg with 12 leads; tracing only, without interpretation and report, performed as a screening for the initial preventive physical examination <1% 61 $103.63
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 793 $100.00
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 990 $95.63
Q9956 Injection, octafluoropropane microspheres, per ml <1% 342 $86.84
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,561 $78.23
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,759 $70.03
J1171 Injection, hydromorphone, 0.1 mg <1% 110 $68.58
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed <1% 13 $63.06
J1650 Injection, enoxaparin sodium, 10 mg <1% 103 $60.57
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,310 $57.30
J1040 Injection, methylprednisolone acetate, 80 mg <1% 248 $53.56
J2060 Injection, lorazepam, 2 mg <1% 355 $53.36
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 298 $51.49
82150 <1% 30 $35.82
J7060 5% dextrose/water (500 ml = 1 unit) <1% 523 $35.21
J8540 Dexamethasone, oral, 0.25 mg <1% 108 $34.56
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 87 $34.50
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 158 $34.43
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 271 $33.92
J7050 Infusion, normal saline solution, 250 cc <1% 649 $29.69
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 676 $28.32
81002 <1% 541 $27.97
J1630 Injection, haloperidol, up to 5 mg <1% 142 $27.46
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 111 $25.96
J3475 Injection, magnesium sulfate, per 500 mg <1% 331 $20.97
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 217 $16.95
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 335 $14.92
J0690 Injection, cefazolin sodium, 500 mg <1% 299 $13.64
A4217 Sterile water/saline, 500 ml <1% 67 $13.36
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 324 $12.57
J2470 Injection, pantoprazole sodium, 40 mg <1% 32 $10.25
J1010 Injection, methylprednisolone acetate, 1 mg <1% 16 $8.22
J1030 Injection, methylprednisolone acetate, 40 mg <1% 95 $7.42
J7999 Compounded drug, not otherwise classified <1% 52 $5.22
Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml <1% 95 $4.57
J1815 Injection, insulin, per 5 units <1% 56 $4.28
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 441 $3.83
J3480 Injection, potassium chloride, per 2 meq <1% 34 $2.33
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 118 $1.68
J1940 Injection, furosemide, up to 20 mg <1% 43 $1.17
J2004 Injection, lidocaine hcl with epinephrine, 1 mg <1% 44 $0.87
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 38 $0.72
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 246 $0.52
A9270 Non-covered item or service <1% 8,696 $0.39
88312 0% 12 $0.00
A4649 Surgical supply; miscellaneous 0% 15 $0.00
00811 0% 332 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 79 $0.00
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose 0% 238 $0.00
J2550 Injection, promethazine hcl, up to 50 mg 0% 29 $0.00
0753T 0% 111 $0.00
C1887 Catheter, guiding (may include infusion/perfusion capability) 0% 57 $0.00
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 0% 46 $0.00
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 0% 55 $0.00
01810 0% 17 $0.00
J0670 Injection, mepivacaine hydrochloride, per 10 ml 0% 13 $0.00
J2785 Injection, regadenoson, 0.1 mg 0% 135 $0.00
76377 0% 248 $0.00
00813 0% 208 $0.00
C1769 Guide wire 0% 219 $0.00
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) 0% 27 $0.00
J2795 Injection, ropivacaine hydrochloride, 1 mg 0% 38 $0.00
J1790 Injection, droperidol, up to 5 mg 0% 13 $0.00
82803 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSCHILLERO, ANTHONY (DIRECTOR, FP&A)
Same official

Other billing entities under SCHILLERO, ANTHONY

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.